SalI-HF®

Restriction Enzymes SalI

Experiment
Restriction Enzymes SalI
Product
SalI-HF® from New England BioLabs
Manufacturer
New England BioLabs

Protocol tips

Protocol tips
The thereby assembled complementation cassette was gel-purified, verified by sequencing and further cleaved by EagI-HF (NEB) and SalI-HF (NEB) following manual’s instructions. Analogously, respective pENTRY-miniCR-constructs (see above) were cleaved by the same enzymes, respectively, as a EagI and a SalI restriction site are sequentially located 5 bp upstream of the truncated leader promoter (cf. Fig. 2a).

Publication protocol

For complementation constructs, the slaB gene of S. islandicus M.16.4 (M.16.4_1762, DNA, and S. solfataricus were aligned, which revealed M.16.4 slaB 4 and 10 mismatches in complementary regions of protospacers PS2 and PS3, respectively (cf. Fig. 2b). As mismatches were scattered throughout PS3, and PS2 exhibited two mismatches towards the 3′-end, which is considered important for target cleavage50, slaB-M.16.4 was considered divergent enough to avoid cross-targeting of simultaneously expressed SB2 and SB3-crRNAs. For creation of complementation cassettes, first the araS promoter of S. solfataricus P234 was PCR-amplified (Phusion Polymerase, ThermoFisher, Scientific) using araFW_EagI and araOH_MSlaB_RV primers (Supplementary Table 1), which added an EagI recognition site to the 5′ and an overhang consisting of the first 25 nt of the slaB-M.16.4 sequence (see below) to the 3′-end of the araS sequence, respectively. The sequence chosen for slaB-M.16.4 expression contained the slaB-M.16.4 coding sequence (CDS), as well as the 11 bp 5′-UTR containing a RBS38, as well as the putative terminator sequence downstream to the CDS (genome coordinates: 1615528–1614238, GenBank: CP001402.1). This region was amplified (DNA extracted from S. islandicus M.16.4 obtained from the Rachel Whitaker Laboratory) using primers SlaBM164_FW and SlaBM164_SalI_RV, thereby adding a SalI restriction site to its 3′-end (Supplementary Table 1). AraS and slaB-M.16.4 PCR products were gel-purified (Monarch Gel purification kit, NEB) and subsequently fused at the homologous overlap region using primers araFW_EagI and SlaBM164_SalI_RV, in a touch-down PCR reaction (Supplementary Table 1). The thereby assembled complementation cassette was gel-purified, verified by sequencing and further cleaved by EagI-HF (NEB) and SalI-HF (NEB) following manual’s instructions. Analogously, respective pENTRY-miniCR-constructs (see above) were cleaved by the same enzymes, respectively, as a EagI and a SalI restriction site are sequentially located 5 bp upstream of the truncated leader promoter (cf. Fig. 2a). Finally, the complementation cassette was ligated upstream to the miniCR cassette into the respective pENTRY vectors (Quick-Ligase, NEB), generating ENTRY-SB2-CC, pENTRY-SB3×6-CC, and pENTRY-Ctrl-CC, respectively which were recovered by E. coli propagation (One Shot TOP 10, ThermoFisher Scientific).

Full paper   Login or join for free to view the full paper.

Reviews

SalI-HF® from New England BioLabs has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Restriction Enzymes SalI using SalI-HF® from New England BioLabs.

View full paper   Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from New England BioLabs for SalI-HF® below.

We haven't found the manufacturer protocol for this product yet.

Videos

Check out videos that might be relevant for performing Restriction Enzymes SalI using SalI-HF® from New England BioLabs. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms